- SG$10.07m
- SG$7.13m
- SG$18.28m
- 33
- 69
- 27
- 35
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.8 | 21.4 | 23.9 | 23.2 | 18.3 |
Cost of Revenue | |||||
Gross Profit | 12.4 | 11.3 | 11.6 | 11.3 | 8.52 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20.1 | 16.3 | 13.4 | 25.7 | 29.5 |
Operating Profit | 3.7 | 5.08 | 10.5 | -2.48 | -11.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3.56 | 4.95 | 10.4 | -2.53 | -11.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.87 | 4.18 | 9.51 | -3.24 | -11.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.08 | 3.35 | 9.07 | -3.51 | -8.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.08 | 3.35 | 9.07 | -3.51 | -8.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.071 | 0.105 | 0.237 | -0.11 | -0.178 |
Dividends per Share |